Cyclic amino compounds for use in the treatment of cardiac disorders
The present invention relates to tertiary amines of formula (I) for use in therapy, particularly for use in treating cardiovascular disorders. The compounds have been found to regulate phospholamban phosphorylation by interfering with the A-kinase anchor protein 18delta (AKAP18δ) binding to the PKA...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
07.03.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to tertiary amines of formula (I) for use in therapy, particularly for use in treating cardiovascular disorders. The compounds have been found to regulate phospholamban phosphorylation by interfering with the A-kinase anchor protein 18delta (AKAP18δ) binding to the PKA substrate phospholamban. The compounds share a tri(alkylaryl/alkylheteroaryl) amine structure. |
---|---|
Bibliography: | Application Number: US201414549414 |